Arthur Amron - Dec 14, 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Arthur H. Amron
Stock symbol
NEPH
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
4
Date filed
12/16/2021, 08:16 PM
Previous filing
Jun 4, 2021
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Award $0 +4.58K $0.00 4.58K Dec 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (Right to Buy) Award $0 +7.06K $0.00 7.06K Dec 14, 2021 Common Stock 7.06K $6.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
F2 On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.